| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2036.2011.04668.X |
| P698 | PubMed publication ID | 21517924 |
| P50 | author | Antonio Craxì | Q37836606 |
| Salvatore Petta | Q41498162 | ||
| Daniela Cabibi | Q53100665 | ||
| Vito Di Marco | Q56863476 | ||
| P2093 | author name string | C Cammà | |
| G Butera | |||
| P2860 | cites work | Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 |
| Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis | Q30448524 | ||
| Liver biopsy | Q33932981 | ||
| Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. | Q34390093 | ||
| Performance of transient elastography for the staging of liver fibrosis: a meta-analysis | Q34590187 | ||
| Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis | Q34830398 | ||
| Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive | Q37310296 | ||
| Non-alcoholic fatty liver disease pathogenesis: the present and the future | Q37395200 | ||
| Systematic review: caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease. | Q37600924 | ||
| Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association | Q37730153 | ||
| Feasibility of liver transient elastography with FibroScan using a new probe for obese patients | Q43056991 | ||
| Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease | Q44244167 | ||
| Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). | Q46857868 | ||
| Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. | Q53039947 | ||
| Reliability of transient elastography for the detection of fibrosis in Non-Alcoholic Fatty Liver Disease and chronic viral hepatitis | Q54513263 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| non-alcoholic fatty liver | Q66299798 | ||
| P304 | page(s) | 1350-1360 | |
| P577 | publication date | 2011-04-25 | |
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index | |
| P478 | volume | 33 |
| Q40238088 | A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B. |
| Q30442208 | A health technology assessment of transient elastography in adult liver disease |
| Q37995326 | Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques |
| Q39278672 | Assessment of transient elastography in Japanese patients with non-alcoholic fatty liver disease |
| Q35989613 | Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease |
| Q91927091 | Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound |
| Q26768262 | Clinical applications, limitations and future role of transient elastography in the management of liver disease |
| Q48234623 | Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods. |
| Q39395098 | Detecting fibrosis without a liver biopsy: getting to the fat of the issue |
| Q64065840 | Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis |
| Q30374016 | Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis |
| Q30389544 | Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. |
| Q99564944 | Difference in lifestyle and metabolic profile of non-alcoholic fatty liver disease with raised alanine amino-transferases between obese and non-overweight subjects |
| Q48333919 | Do we need controlled attenuation parameter adjustment for fibrosis estimation in nonalcoholic fatty liver disease patients? |
| Q41440068 | Factors Associated with the Quality of Transient Elastography. |
| Q39679345 | Feasibility of liver stiffness measurement in morbidly obese patients undergoing bariatric surgery using XL probe. |
| Q36413703 | Focus on therapeutic strategies of nonalcoholic Fatty liver disease |
| Q51161258 | Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. |
| Q89762758 | Improvement in liver stiffness measurement for diagnosis of liver fibrosis in patients with concurrent chronic hepatitis B and nonalcoholic fatty liver disease |
| Q36781591 | Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable? |
| Q58803232 | Is liver stiffness measurement unreliable in obese patients? authors’ reply |
| Q26780252 | Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance. |
| Q47612256 | Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease. |
| Q51308971 | Liver stiffness and portal blood flow modifications induced by a liquid meal consumption: pathogenetic mechanisms and clinical relevance. |
| Q47942345 | Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy |
| Q44403442 | Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation |
| Q30403258 | MR Elastography of Liver Disease: State of the Art. |
| Q30372813 | Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis |
| Q58602760 | Methods to improve the noninvasive diagnosis and assessment of disease severity in children with suspected nonalcoholic fatty liver disease (NAFLD): Study design |
| Q26744631 | Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy? |
| Q38494198 | Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives |
| Q43507851 | Nonalcoholic fatty liver disease in Asia: a story of growth |
| Q38141711 | Noninvasive evaluation of NAFLD. |
| Q42613401 | Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy. |
| Q90575483 | Optimal liver stiffness measurement values for the diagnosis of significant fibrosis and cirrhosis in chronic liver disease in Singapore |
| Q53120583 | Pediatric Non-alcoholic Fatty Liver Disease. |
| Q45066338 | Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease |
| Q40082339 | Predicting the risk of postoperative liver failure and overall survival using liver and spleen stiffness measurements in patients with hepatocellular carcinoma |
| Q36306317 | Presence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population |
| Q49669430 | Repeated liver stiffness measurement compared with paired liver biopsy in patients with non-alcoholic fatty liver disease |
| Q38070696 | Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. |
| Q34440962 | Review article: the management of paediatric nonalcoholic fatty liver disease |
| Q36880302 | The Performance of Vibration Controlled Transient Elastography in a US Cohort of Patients With Nonalcoholic Fatty Liver Disease |
| Q51089882 | The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease. |
| Q38117079 | The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis |
| Q38656970 | The role of bariatric surgery in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis |
| Q58803093 | The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease |
| Q57597714 | Transient elastography identifies liver recipients with nonviral graft disease after transplantation: A guide for liver biopsy |
| Q38359165 | Ultrasound elastography: liver |
| Q47803154 | Usefulness of the index of NASH - ION for the diagnosis of steatohepatitis in patients with non-alcoholic fatty liver: An external validation study |
| Q90205951 | Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis |
| Q53100804 | Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease |
| Q41392739 | WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver |
Search more.